SHREE GANESH REMEDIES Financial Statement Analysis
|
||
|
The Revenues of SHREE GANESH REMEDIES have decreased by -100.00% YoY .
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has decreased by -17.91 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SHREE GANESH REMEDIES Last 5 Annual Financial Results
[BOM: 540737]
| Consolidated | Mar2025 | Mar2024 | Mar2020 | Mar2019 |
|---|---|---|---|---|
| Revenues | ₹126 Cr | ₹6,401,872 Cr | ₹35 Cr | ₹35 Cr |
| Expenses | ₹84 Cr | ₹5,150,123 Cr | ₹27 Cr | ₹27 Cr |
| Operating Profit (Excl OI) | ₹42 Cr | ₹1,251,750 Cr | ₹8.74 Cr | ₹8.74 Cr |
| Other Income | ₹3.07 Cr | ₹390,970 Cr | ₹1.17 Cr | ₹1.17 Cr |
| Interest | ₹0.61 Cr | ₹54,250 Cr | ₹0.20 Cr | ₹0.20 Cr |
| Depreciation | ₹6.11 Cr | ₹229,473 Cr | ₹1.04 Cr | ₹1.04 Cr |
| Profit Before Tax | ₹38 Cr | ₹1,358,996 Cr | ₹8.67 Cr | ₹8.67 Cr |
| Profit After Tax | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
| Consolidated Net Profit | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
| Earnings Per Share (Rs) | ₹17.97 | ₹21.89 | ₹11.67 | ₹6.95 |
| PAT Margin (%) | 20.71 | 21.73 | 16.36 | 17.66 |
| ROE(%) | 17.26 | 34.22 | 27.55 | 18.43 |
| ROCE(%) | 19.53 | 37.81 | 34.79 | 25.66 |
| Total Debt/Equity(x) | 0.26 | 0.30 | 0.11 | 0.02 |
Key Financials |
||
| Market Cap | : | ₹ 628.5 Cr |
| Revenue (TTM) | : | ₹ 108.5 Cr |
| Net Profit(TTM) | : | ₹ 21.9 Cr |
| EPS (TTM) | : | ₹ 17.1 |
| P/E (TTM) | : | 28.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SHREE GANESH REMEDIES | -2.8% | -9.9% | -36% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.3% | 4.1% | -9.9% |
| DIVIS LABORATORIES | -1.7% | 8.5% | 13.2% |
| CIPLA | -3.4% | 3% | 4.8% |
| TORRENT PHARMACEUTICALS | 0.7% | -0.5% | 7.2% |
| DR REDDYS LABORATORIES | 0.2% | -1.1% | -3.6% |
| MANKIND PHARMA | -1.6% | -4.5% | -5.3% |
| ZYDUS LIFESCIENCES | 1.2% | -2.1% | 1.8% |
| LUPIN | -1.2% | -3.5% | -9.4% |
SHREE GANESH REMEDIES Revenues
[BOM: 540737]
| Y-o-Y | -100.00 % |
| 5 Yr CAGR | 52.76 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹126 Cr | -100.00 | |
| Mar2024 | ₹6,401,872 Cr | 18,128,325.92 | |
| Mar2020 | ₹35 Cr | 0.00 | |
| Mar2019 | ₹35 Cr | - | |
SHREE GANESH REMEDIES Operating Profit
[BOM: 540737]
| Y-o-Y | -100.00 % |
| 5 Yr CAGR | 68.47 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | -100.00 | |
| Mar2024 | ₹1,251,750 Cr | 14,317,065.25 | |
| Mar2020 | ₹8.74 Cr | 0.00 | |
| Mar2019 | ₹8.74 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 69.87 % |
| 5 Yr CAGR | 10.28 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 33.21% | 69.87 | |
| Mar2024 | 19.55% | -21.04 | |
| Mar2020 | 24.76% | 0.00 | |
| Mar2019 | 24.76% | - | |
SHREE GANESH REMEDIES Profit After Tax
[BOM: 540737]
| Y-o-Y | -100.00 % |
| 5 Yr CAGR | 65.20 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | -100.00 | |
| Mar2024 | ₹1,047,056 Cr | 16,793,096.95 | |
| Mar2020 | ₹6.24 Cr | 0.00 | |
| Mar2019 | ₹6.24 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -4.69 % |
| 5 Yr CAGR | 5.45 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 20.71 % | -4.69 | |
| Mar2024 | 21.73 % | 32.82 | |
| Mar2020 | 16.36 % | -7.36 | |
| Mar2019 | 17.66 % | - | |
SHREE GANESH REMEDIES Earnings Per Share (EPS)
[BOM: 540737]
| Y-o-Y | -17.91 % |
| 5 Yr CAGR | 37.25 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 | -17.91 | |
| Mar2024 | ₹22 | 87.57 | |
| Mar2020 | ₹12 | 67.91 | |
| Mar2019 | ₹6.95 | - | |
SHREE GANESH REMEDIES Return on Capital Employed (ROCE)
[BOM: 540737]
| Y-o-Y | -48.35 % |
| 5 Yr CAGR | -8.70 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 19.53% | -48.35 | |
| Mar2024 | 37.81% | 8.68 | |
| Mar2020 | 34.79% | 35.58 | |
| Mar2019 | 25.66% | - | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Current Share Price | : | ₹491.0 |
| Current MarketCap | : | ₹ 628.5 Cr |
| Updated EOD on | : | Oct 27,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -2.8% |
-9.9% |
-36% |
| SENSEX | 1% |
3.3% |
4.5% |
SHREE GANESH REMEDIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE SMALLCAP | 1.4% | -0.5% | -3.3% |
| BSE HEALTHCARE | -0.1% | 0.6% | 2.3% |
No NSE index found
You may also like the below Video Courses
FAQ about SHREE GANESH REMEDIES Financials
How the annual revenues of SHREE GANESH REMEDIES have changed ?
The Revenues of SHREE GANESH REMEDIES have decreased by -100.00% YoY .
How the Earnings per Share (EPS) of SHREE GANESH REMEDIES have changed?
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has decreased by -17.91 % YoY .
Check out Intrinsic Value of Peers of SHREE GANESH REMEDIES
Compare Stock Analytics of Peers of SHREE GANESH REMEDIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
